AFM and gestational diabetes: To further evaluate the biomarker potential of afamin, SAMP and vitronectin as compared to maternal age and the maternal risk factors currently used in routine GDM screening, a number of binominal logistic regression analyses were performed using the data from the validation set (n = 210).